---
title: "Meinian Onehealth has established a new medical testing laboratory company in Chengdu"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/256299987.md"
description: "According to the Qichacha APP, recently, Chengdu Meinian Medical Laboratory Co., Ltd. was established with a registered capital of 10 million yuan. The business scope includes: inspection and testing services; operation of Class III medical devices; development of human genetic diagnosis and treatment technology; information system integration services, etc. Qichacha's equity penetration shows that the company is wholly owned by Meinian Onehealth indirectly"
datetime: "2025-09-08T01:45:41.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/256299987.md)
  - [en](https://longbridge.com/en/news/256299987.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/256299987.md)
---

# Meinian Onehealth has established a new medical testing laboratory company in Chengdu

According to the Qichacha APP, recently, Chengdu Meinian Medical Laboratory Co., Ltd. was established with a registered capital of 10 million yuan. The business scope includes: inspection and testing services; operation of Class III medical devices; development of human genetic diagnosis and treatment technology; information system integration services, etc. Qichacha's equity penetration shows that the company is wholly owned by Meinian Onehealth indirectly

### Related Stocks

- [002044.CN](https://longbridge.com/en/quote/002044.CN.md)

## Related News & Research

- [CDC lifts beneficial stake in Exosens to 11.71% of capital, 13.87% of voting rights](https://longbridge.com/en/news/296499698.md)
- [Focus Media Information Technology Co: Net profit jumped 17.39% to ¥3.13 billion despite a slight revenue dip, with strong cash flow](https://longbridge.com/en/news/296251196.md)
- [Frozen blueberries recall categorized under FDA's highest Class I risk level](https://longbridge.com/en/news/296506599.md)
- [Monzo users locked out of accounts after tech meltdown](https://longbridge.com/en/news/296368027.md)
- [BUZZ-Faeth Therapeutics rises after FDA grants fast-track status for cancer drug](https://longbridge.com/en/news/296104768.md)